{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:43Z","timestamp":1791838183990,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K11193"],"award-info":[{"award-number":["17K11193"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Co Ltd","doi-asserted-by":"publisher","award":["2019-0004"],"award-info":[{"award-number":["2019-0004"]}],"id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jiac.2021.11.011","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T16:28:48Z","timestamp":1637771328000},"page":"377-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-5077","authenticated-orcid":false,"given":"Ryoichi","family":"Hamasuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hanzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Moritomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-3595","authenticated-orcid":false,"given":"Masahiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisami","family":"Aono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikko","family":"Tomisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5256-6415","authenticated-orcid":false,"given":"Naohiro","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-7435","authenticated-orcid":false,"given":"J\u00f8rgen Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.11.011_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/CMR.00006-11","article-title":"Mycoplasma genitalium: from Chrysalis to multicolored butterfly","volume":"24","author":"Taylor-Robinson","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2021.11.011_bib2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1086\/593188","article-title":"Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance","volume":"47","author":"Jensen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.011_bib3","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1093\/infdis\/jix132","article-title":"New horizons in mycoplasma genitalium treatment","volume":"216","author":"Bradshaw","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.011_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid1207.051558","article-title":"Azithromycin failure in Mycoplasma genitalium urethritis","volume":"12","author":"Bradshaw","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.011_bib5","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/AAC.00724-09","article-title":"Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR","volume":"53","author":"Hamasuna","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2021.11.011_bib6","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/AAC.02411-14","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2021.11.011_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198355","article-title":"Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains","volume":"13","author":"Hamasuna","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2021.11.011_bib8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0956462413502008","article-title":"Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance","volume":"24","author":"Couldwell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jiac.2021.11.011_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jiac.2017.03.008","article-title":"Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan","volume":"23","author":"Deguchi","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.11.011_bib10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.011_bib11","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1128\/JCM.00495-13","article-title":"Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium","volume":"51","author":"Tagg","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.11.011_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3201\/eid2305.161745","article-title":"Increasing macrolide and fluoroquinolone resistance in mycoplasma genitalium","volume":"23","author":"Murray","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.011_bib13","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/AAC.01956-12","article-title":"Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium","volume":"57","author":"Yamaguchi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2021.11.011_bib14","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3201\/eid2209.160446","article-title":"Fluoroquinolone-resistant mycoplasma genitalium, southwestern France","volume":"22","author":"Le Roy","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.011_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jiac.2018.08.009","article-title":"Surveillance of the prevalence of macrolide and\/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan","volume":"24","author":"Deguchi","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.11.011_bib16","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/jam.14359","article-title":"The impact of sample storage on molecular-based detection of Mycoplasma genitalium","volume":"127","author":"Murray","year":"2019","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jiac.2021.11.011_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/15734099113099990004","article-title":"Molecular determinants of the bacterial resistance to fluoroquinolones: a computational study","volume":"9","author":"Lupala","year":"2013","journal-title":"Curr Comput Aided Drug Des"},{"key":"10.1016\/j.jiac.2021.11.011_bib18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jiac.2021.11.011_bib19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jiac.2021.11.011_bib20","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.1038\/ncomms10048","article-title":"Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin","volume":"6","author":"Chan","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2021.11.011_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JCM.02056-06","article-title":"Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with Vero cells","volume":"45","author":"Hamasuna","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.11.011_bib22","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1128\/AAC.49.12.4993-4998.2005","article-title":"Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR","volume":"49","author":"Hamasuna","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2021.11.011_bib23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jac\/48.5.742","article-title":"Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment","volume":"48","author":"Deguchi","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2021.11.011_bib24","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jiac.2021.11.011_bib25","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160157","article-title":"Exploring the active site of the Streptococcus pneumoniae topoisomerase IV-DNA cleavage complex with novel 7,8-bridged fluoroquinolones","volume":"6","author":"Laponogov","year":"2016","journal-title":"Open Biol"},{"key":"10.1016\/j.jiac.2021.11.011_bib26","author":"Laponogov"},{"key":"10.1016\/j.jiac.2021.11.011_bib27","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/JCM.02312-16","article-title":"Prospective evaluation of ResistancePlus MG, a new multiplex quantitative PCR assay for detection of mycoplasma genitalium and macrolide resistance","volume":"55","author":"Tabrizi","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2021.11.011_bib28","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.011_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bioorg.2018.08.031","article-title":"Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1,2,4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors","volume":"81","author":"Mohamed","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jiac.2021.11.011_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13065-017-0295-z","article-title":"Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis","volume":"11","author":"Anguru","year":"2017","journal-title":"Chem Cent J"},{"key":"10.1016\/j.jiac.2021.11.011_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1570163814666170829142044","article-title":"Molecular modeling studies of novel fluoroquinolone molecules","volume":"15","author":"Allaka","year":"2018","journal-title":"Curr Drug Discov Technol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:24Z","timestamp":1761159804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21003226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1341321X21003226"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.11.011","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}